Original Research
Published on 05 Feb 2026
Tocilizumab combined with short-term high-dose glucocorticoids for rapid disease activity control and glucocorticoid reduction in adult-onset Still’s disease: a single-center retrospective study
- 450 views
Original Research
Published on 05 Feb 2026
Review
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Case Report
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Review
Published on 05 Feb 2026
Review
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Correction
Published on 05 Feb 2026
Mini Review
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Mini Review
Published on 05 Feb 2026
Correction
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Systematic Review
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Original Research
Published on 05 Feb 2026
Review
Published on 05 Feb 2026
Case Report
Published on 05 Feb 2026
Original Research
Accepted on 04 Feb 2026